Completed PHASE3 INTERVENTIONAL NCT00003607

Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer

Phase III Randomized Study of Radiotherapy to the Prostate With or Without Radiotherapy to the Pelvis in Patients With Stage I, II, or III Adenocarcinoma of the Prostate

Sponsor: UNICANCER

Conditions Prostate Cancer

Interventions radiation therapy

Updated 6 times since 2017 Last updated: Jun 22, 2016 Started: Dec 31, 1997 Primary completion: Dec 31, 2002 Completion: Jan 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Prostate Cancer, this trial is completed. The trial is conducted by UNICANCER and has accumulated 6 data snapshots since 1997. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Dec 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

UNICANCER

Data source: UNICANCER

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Angers, France , Annecy, France , Bordeaux, France , Caen, France , Chalon-sur-Saône, France , Créteil, France , Lille, France , Limoges, France , Lyon, France , Marseille, France and 10 more locations